Literature DB >> 17376899

Elevated expression levels of inhibitory receptor programmed death 1 on simian immunodeficiency virus-specific CD8 T cells during chronic infection but not after vaccination.

Vijayakumar Velu1, Sunil Kannanganat, Chris Ibegbu, Lakshmi Chennareddi, Francois Villinger, Gordon J Freeman, Rafi Ahmed, Rama Rao Amara.   

Abstract

Here, we study the temporal expression of the inhibitory receptor programmed death 1 (PD-1) on simian immunodeficiency virus (SIV) Gag-specific T cells following pathogenic SIV infection or following vaccination with a DNA/modified vaccinia virus Ankara (DNA/MVA) vaccine and simian/human immunodeficiency virus (SHIV) challenge in macaques. Following infection, the majority (>95%) of Gag-specific CD8 T cells expressed PD-1, and the level of PD-1 expression per cell increased over time. The level of PD-1 expression in lymph nodes and rectal mucosal tissue, the major sites of virus replication, was higher compared to blood. In vitro blockade of PD-1 resulted in enhanced proliferation of SIV-specific CD8 as well as CD4 T cells. In contrast, following vaccination, the majority of peak effector Gag-specific CD8 T cells expressed low levels of PD-1, and these levels decreased further as the cells differentiated into memory cells. In addition, following SHIV challenge of these vaccinated macaques, the level of PD-1 expression on Gag-specific CD8 T cells correlated positively with plasma viremia. These results demonstrate that SIV-specific CD8 T cells express PD-1 after exposure to antigen but downregulate expression under conditions of antigen clearance and enhance expression under conditions of antigen persistence. They also demonstrate that the level of PD-1 expression per cell rather than the presence or absence of expression plays an important role in regulating CD8 T-cell dysfunction in pathogenic SIV infection. In addition, they demonstrate that similar to HIV infection, the PD-1:PD-1 ligand inhibitory pathway is operational in pathogenic SIV infection, and the macaque/SIV model would be ideal to test the safety and therapeutic benefit of blocking this pathway in vivo.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17376899      PMCID: PMC1900286          DOI: 10.1128/JVI.00024-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Memory CD8 T-cell differentiation during viral infection.

Authors:  E John Wherry; Rafi Ahmed
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

Review 2.  The B7 family revisited.

Authors:  Rebecca J Greenwald; Gordon J Freeman; Arlene H Sharpe
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

Review 3.  T cell vaccines for microbial infections.

Authors:  Harriet L Robinson; Rama Rao Amara
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 4.  T cells and viral persistence: lessons from diverse infections.

Authors:  Paul Klenerman; Ann Hill
Journal:  Nat Immunol       Date:  2005-09       Impact factor: 25.606

5.  Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag.

Authors:  Danilo R Casimiro; Fubao Wang; William A Schleif; Xiaoping Liang; Zhi-Qiang Zhang; Timothy W Tobery; Mary-Ellen Davies; Adrian B McDermott; David H O'Connor; Arthur Fridman; Ansu Bagchi; Lynda G Tussey; Andrew J Bett; Adam C Finnefrock; Tong-ming Fu; Aimin Tang; Keith A Wilson; Minchun Chen; Helen C Perry; Gwendolyn J Heidecker; Daniel C Freed; Anthony Carella; Kara S Punt; Kara J Sykes; Lingyi Huang; Virginia I Ausensi; Margaret Bachinsky; Usha Sadasivan-Nair; David I Watkins; Emilio A Emini; John W Shiver
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

6.  A combination DNA and attenuated simian immunodeficiency virus vaccine strategy provides enhanced protection from simian/human immunodeficiency virus-induced disease.

Authors:  Rama Rao Amara; Kalpana Patel; Genevieve Niedziela; Pragati Nigam; Sunita Sharma; Silvija I Staprans; David C Montefiori; Lakshmi Chenareddi; James G Herndon; Harriet L Robinson; Harold M McClure; Francis J Novembre
Journal:  J Virol       Date:  2005-12       Impact factor: 5.103

7.  Association between virus-specific cytotoxic T-lymphocyte and helper responses in human immunodeficiency virus type 1 infection.

Authors:  S A Kalams; S P Buchbinder; E S Rosenberg; J M Billingsley; D S Colbert; N G Jones; A K Shea; A K Trocha; B D Walker
Journal:  J Virol       Date:  1999-08       Impact factor: 5.103

8.  Biodistribution and persistence of an MVA-vectored candidate HIV vaccine in SIV-infected rhesus macaques and SCID mice.

Authors:  Tomás Hanke; Andrew J McMichael; Michael J Dennis; Sally A Sharpe; Lindsey A J Powell; Lorraine McLoughlin; Steven J Crome
Journal:  Vaccine       Date:  2005-02-10       Impact factor: 3.641

9.  Restoring function in exhausted CD8 T cells during chronic viral infection.

Authors:  Daniel L Barber; E John Wherry; David Masopust; Baogong Zhu; James P Allison; Arlene H Sharpe; Gordon J Freeman; Rafi Ahmed
Journal:  Nature       Date:  2005-12-28       Impact factor: 49.962

10.  CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms.

Authors:  Richard V Parry; Jens M Chemnitz; Kenneth A Frauwirth; Anthony R Lanfranco; Inbal Braunstein; Sumire V Kobayashi; Peter S Linsley; Craig B Thompson; James L Riley
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

View more
  81 in total

1.  Programmed cell death-1 single-nucleotide polymorphism rs10204525 is associated with human immunodeficiency virus type 1 RNA viral load in HIV-1-infected Moroccan subjects.

Authors:  Hanâ Baba; Anass Kettani; Meryem Bouqdayr; Ahd Ouladlahsen; Rajaa Bensghir; Latifa Marih; Mustapha Sodqi; Soumaya Benjelloun; Sayeh Ezzikouri; Imane Zaidane; Fatima-Zahra Jadid; Kamal Marhoum El Filali; Lahcen Wakrim
Journal:  Med Microbiol Immunol       Date:  2021-05-24       Impact factor: 3.402

2.  Immunization with different viral antigens alters the pattern of T cell exhaustion and latency in herpes simplex virus type 1-infected mice.

Authors:  Sariah J Allen; Kevin R Mott; Mandana Zandian; Homayon Ghiasi
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

3.  Preexisting vaccinia virus immunity decreases SIV-specific cellular immunity but does not diminish humoral immunity and efficacy of a DNA/MVA vaccine.

Authors:  Sunil Kannanganat; Pragati Nigam; Vijayakumar Velu; Patricia L Earl; Lilin Lai; Lakshmi Chennareddi; Benton Lawson; Robert L Wilson; David C Montefiori; Pamela A Kozlowski; Bernard Moss; Harriet L Robinson; Rama Rao Amara
Journal:  J Immunol       Date:  2010-11-12       Impact factor: 5.422

Review 4.  Role of PD-L1 and PD-L2 in allergic diseases and asthma.

Authors:  A K Singh; P Stock; O Akbari
Journal:  Allergy       Date:  2010-08-17       Impact factor: 13.146

Review 5.  Revisiting immune exhaustion during HIV infection.

Authors:  Alka Khaitan; Derya Unutmaz
Journal:  Curr HIV/AIDS Rep       Date:  2011-03       Impact factor: 5.071

6.  Early resolution of acute immune activation and induction of PD-1 in SIV-infected sooty mangabeys distinguishes nonpathogenic from pathogenic infection in rhesus macaques.

Authors:  Jacob D Estes; Shari N Gordon; Ming Zeng; Ann M Chahroudi; Richard M Dunham; Silvija I Staprans; Cavan S Reilly; Guido Silvestri; Ashley T Haase
Journal:  J Immunol       Date:  2008-05-15       Impact factor: 5.422

7.  Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.

Authors:  Shawn D Blackburn; Alison Crawford; Haina Shin; Antonio Polley; Gordon J Freeman; E John Wherry
Journal:  J Virol       Date:  2009-12-02       Impact factor: 5.103

8.  Activation drives PD-1 expression during vaccine-specific proliferation and following lentiviral infection in macaques.

Authors:  David A Hokey; F Brad Johnson; Jasmine Smith; Joshua L Weber; Jian Yan; Lauren Hirao; Jean D Boyer; Mark G Lewis; George Makedonas; Michael R Betts; David B Weiner
Journal:  Eur J Immunol       Date:  2008-05       Impact factor: 5.532

9.  Upregulation of interleukin 7 receptor alpha and programmed death 1 marks an epitope-specific CD8+ T-cell response that disappears following primary Epstein-Barr virus infection.

Authors:  Delphine Sauce; Martin Larsen; Rachel J M Abbott; Andrew D Hislop; Alison M Leese; Naeem Khan; Laura Papagno; Gordon J Freeman; Alan B Rickinson
Journal:  J Virol       Date:  2009-07-15       Impact factor: 5.103

10.  Differential Inhibitory Receptor Expression on T Cells Delineates Functional Capacities in Chronic Viral Infection.

Authors:  Jeffrey E Teigler; Gennadiy Zelinskyy; Michael A Eller; Diane L Bolton; Mary Marovich; Alexander D Gordon; Aljawharah Alrubayyi; Galit Alter; Merlin L Robb; Jeffrey N Martin; Steven G Deeks; Nelson L Michael; Ulf Dittmer; Hendrik Streeck
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.